ORTOSKIN SLP
Company details
- Active NIF/CIF: B57027278
-
-
-
-
Address: Not available
-
-
Featured products:
More information on ORTOSKIN SLP
-
16/09/2011 | BORME act no.: 534720 | Register: ILLES BALEARSDepósito de cuentas anuales (Septiembre de 2011)
-
26/08/2010 | BORME act no.: 381875 | Register: ILLES BALEARSDepósito de cuentas anuales (Agosto de 2010)
-
03/09/2009 | BORME act no.: 312629 | Register: ILLES BALEARSDepósito de cuentas anuales (Agosto de 2009)
-
10/09/2008 | BORME act no.: 445409 | Register: ILLES BALEARSDepósito de cuentas anuales (Agosto de 2008)
-
05/05/2008 | BORME act no.: 224960 | Register: ILLES BALEARSOtros conceptos
-
05/05/2008 | BORME act no.: 224960 | Register: ILLES BALEARSCambio de objeto social
Other information
The CIF assigned to ORTOSKIN SLP is B57027278, while its current business status is active. The company operates in the economic sector identified by the CNAE 8621 - Medical practice activities. In addition, its activity corresponds to the SIC classification 8069 - Hospitales especializados.
The template of ORTOSKIN SLP includes Between 10 and 49 employees, and the company reports an annual turnover of less than 2 million euros. ORTOSKIN SLP is registered in the Mercantile Registry of Illes balears and accumulates a total of - registration charges. The most recent announcement in Borme was published on 16/09/2011, while its last deposit of ordinary annual accounts is related to the 2023 exercise.
If you want to obtain contact information for ORTOSKIN SLP, such as the telephone number, postal address, or website, you can consult our Company Data module.
To access more details about ORTOSKIN SLP, consider reviewing one of our available financial reports, the company's Annual Accounts, or verifying its outstanding payments registered in the RAI delinquency file.
The financial, commercial, and legal information provided about ORTOSKIN SLP comes from official data sources and is automatically updated every day.
Do you want to know more about ORTOSKIN SLP??
Find out more about this company by consulting these reports: